HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 4, 2013, Pages 487-492

  Pandith, Arshad A ^a   Shah, Zafar A ^a   Khan, Nighat P ^a   Baba, Khalil M ^a   Wani, M Saleem ^a   Siddiqi, Mushtaq A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bladder cancer; Genotype; Kashmiri; PCR RFLP; Polymorphism

Indexed keywords

ADULT; ALLELE; ARTICLE; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CASE CONTROL STUDY; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE H RAS; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION OF BLADDER TUMOR;

CASE-CONTROL STUDIES; DNA, NEOPLASM; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTO-ONCOGENE PROTEINS P21(RAS); RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84876728445     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.03.004     Document Type: Article

References (24)

1. Ploeg M., Aben K.K., Kiemeney L. The present and future burden of urinary bladder cancer in the world. World J Urol 2009, 27:289-293.
2. Clavel J. Progress in the epidemiological understanding of gene environment interactions in major diseases: Cancer. CR Biol 2007, 330:306-317.
3. Clayson D.B. Specific aromatic amines as occupational bladder carcinogens. Natl Cancer Inst Monog 1998, 58:15-19.
4. Ferlay J.V., Bray P., Isani D.M., et al. GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide. IARC Cancer Base No. 5. ver. 2.0 2004, IARC Press, Lyon.
5. Kamarana N.M., Kamat M.R., Kurkure A.P. National Cancer registry project 2000, ICMR, Delhi, India, published in 2003.
6. Dhar G.M., Shah G.N., Naheed B., et al. Epidemiological trend in the distribution of cancer in Kashmir Valley. J Epidemiol Community Health 1993, 47:290-292.
7. Bos J.L. Ras oncogenes in human cancer: A review. Cancer Res 1989, 49:4682-4689.
8. Macaluso M., Russo G., Cinti C., et al. Ras family genes: An interesting link between cell cycle and cancer. J Cell Physiol 2002, 192:125-130.
9. Czerniak B., Cohen G.L., Etkind P. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol 1992, 23:1199-1204.
10. Olderoy G., Daehlin L., Ogreid D. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder. Anticancer Res 1998, 18:2675-2678.
11. Trahey M., McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 1987, 238:542-545.
12. Taparowsky E., Suard Y., Fasano O., et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature (Lond) 1982, 300:762-765.
13. Capon D., Chen E.Y., Levinson A.D., et al. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (Lond) 1983, 302:33-37.
14. Reddy E.P. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science (Wash DC) 1983, 220:1061-1063.
15. Krontiris T.G., Devlin B., Karp D.D., et al. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993, 329:517-523.
16. Kotsinas A., Gorgoulis V.G., Zacharatos P., et al. Additional characterization of a hexanucleotide polymorphic site in the first intron of human HRAS gene: Comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. Cancer Genet Cytogenet 2001, 126:147-154.
17. Johne A., Roots I., Brockmoller J. A single nucleotide polymorphism in the human HRAS proto-oncogene determines the risk of urinary bladder cancer. Cancer Epidemiol Biomarkers Prev 2003, 12:68-70.
18. Yongjing Z., Mingjuan J., Bing L., et al. Association between HRAS T81C genetic polymorphism and gastrointestinal cancer risk: A population-based case-control study in China. BMC Cancer 2008, 8:256.
19. Jebar A.H., Carolyn D.H., Darren C., et al. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 2005, 24:5218-5225.
20. Arshad A.P., Zafar S., Roohi R., et al. Activated H-ras gene mutations in transitional cell carcinoma of urinary the bladder in a Kashmiri population 2010. Tumori 2010, 96:993-998.
21. Sathyan K.M., Nalinakumari K.R., Abraham T., et al. Influence of single nucleotide polymorphisms in HRAS and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 2006, 42:607-613.
22. Lowy D.R., Willumsen B.M. Function and regulation of ras. Annu Rev Biochem 1993, 62:851-891.
23. Trepicchio W.L., Krontiris T.G. Members of the rel/NF-κB family of transcriptional regulatory proteins bind the HRAS1 minisatellite DNA sequence. Nucleic Acids Res 1992, 20:2427-2434.
24. Castro P., Soares P., Gusmao L., et al. HRAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid. Oncogene 2006, 25:4620-4627.